Capital Raising
From Pre-Seed to Series C: Understanding Equity Financing Rounds in Canada
The label attached to a financing round matters less than the milestone the capital is intended to reach. Here is how the stages, structures and investor expectations commonly evolve.
Equity financing is often described as a predictable ladder: founders round, pre-seed, seed, Series A, Series B and Series C. In practice, companies do not progress through a standardized sequence.
A profitable established business may raise growth equity without ever completing a seed round. A technology company may call two consecutive financings “seed.” A strategic investor may invest between formal rounds. Another company may use a bridge, extension or convertible instrument to reach the milestone required for a larger priced round.
The useful question is therefore not simply, “What round are we raising?” It is: what risk has already been removed, what milestone will this capital finance, and what evidence will the next investor expect?
This guide explains the most common labels, the approximate amounts associated with them and the issues Canadian founders and business owners should consider before approaching investors.
A financing round should purchase a measurable increase in enterprise value—not simply more time.
The Labels Are Useful—But They Are Not Rules
Round names are market shorthand. They help investors understand a company’s maturity, probable capital requirement and expected risk, but they have no universal legal definition.
Sector, geography, business model and market conditions can change the meaning of every label. A capital-intensive clean-technology company may require more money before commercialization than a software business. A life-sciences company may be valued around clinical milestones, while a conventional operating company may be assessed primarily on revenue, EBITDA and cash flow.
The amounts below are therefore indicative ranges in Canadian dollars, not thresholds or targets. Public market data also mixes round labels and often reports total round size rather than the amount invested by one investor. CVCA reported an average Canadian pre-seed deal of approximately C$0.83 million in the first half of 2025, while its Q1 2026 data showed an average seed-stage deal of approximately C$4.48 million. U.S. venture benchmarks are generally higher and should not be applied mechanically to Canadian companies.
For current Canadian market context, see CVCA’s Canadian venture-capital reporting.
A Practical Round-by-Round Overview
- Founders / friends-and-family: commonly C$25,000 to C$500,000; used to form the company, validate the problem and build an initial concept.
- Pre-seed: commonly C$100,000 to C$3 million; used to develop an initial product, test demand and assemble the early team.
- Seed: commonly C$1 million to C$5 million; used to demonstrate product-market fit, establish repeatable economics and build commercial traction.
- Series A: commonly C$5 million to C$20 million; used to scale a model that has credible evidence of repeatability.
- Series B: commonly C$15 million to C$40 million; used to accelerate expansion, build organizational depth and strengthen market position.
- Series C and later: often C$30 million and above; used for large-scale expansion, acquisitions, international growth, shareholder liquidity or preparation for an exit.
There is substantial overlap. A C$4 million financing might be called seed by one company and Series A by another. The company’s readiness, the investor group and the financing documents matter more than the label.
Founders Round, Friends-and-Family Round and Angel Round
Founders round
A founders round usually refers to the shares issued when the company is formed or recapitalized among its founders. The contribution may consist of cash, intellectual property, relationships and work performed before outside capital is raised.
Founders should document share ownership, vesting, decision rights and the treatment of intellectual property early. Informal arrangements can become expensive problems when an institutional investor begins diligence.
Friends-and-family round
This is typically the first external capital from people who know the founders personally. It may finance incorporation, research, prototypes, regulatory work or initial sales activity.
Personal trust does not replace proper disclosure or documentation. The company is still issuing securities, conflicts can damage relationships, and investors must qualify under an available prospectus exemption.
Angel round
“Angel” describes the investor more than the stage. Angels are individuals investing their own capital and may participate before, during or after seed. Experienced angels can add industry knowledge, governance discipline and introductions, but founders should understand the investor’s expectations for information, influence and follow-on participation.
Pre-Seed: Proving That the Problem and Solution Are Real
Pre-seed capital generally supports the transition from concept to an initial product or credible proof of concept. The company may have little revenue, and the investment case often rests on the founders, the problem being solved and early evidence that customers care.
Typical uses of capital
- product development and prototyping;
- customer discovery and market validation;
- initial technical and commercial hires;
- regulatory, intellectual-property and incorporation work; and
- testing pricing, distribution and the business model.
What investors commonly assess
At this stage, investors often focus on founder-market fit, the size and urgency of the problem, technical feasibility, the quality of early customer evidence and whether the proposed financing can reach a meaningful milestone.
Pre-seed financings frequently use common shares, preferred shares, convertible notes or simple agreements for future equity. Each structure affects economics, governance and the next round differently.
Seed: Demonstrating Product-Market Fit
A seed round generally finances the work required to turn a promising product into a repeatable business. The company should be moving beyond a good idea toward evidence that customers will buy, remain and generate attractive economics.
Typical uses of capital
- product refinement and reliability;
- sales, marketing and customer acquisition;
- key management and operating hires;
- data, systems and reporting;
- working capital; and
- the milestones needed to support a future Series A.
What investors commonly assess
Relevant evidence may include revenue growth, customer retention, gross margin, sales-cycle length, unit economics, recurring revenue quality, pipeline conversion, regulatory progress and the amount of runway required to reach the next financing or cash-flow breakeven.
A company should be able to explain exactly what the seed round will prove. “Grow the business” is not a financing plan. A stronger case connects the amount raised to specific operating assumptions and measurable milestones.
Series A: Scaling a Model That Has Evidence
Series A is often the first substantial institutional priced round. Investors typically expect a working product, credible customer traction, a defined market and evidence that additional capital can accelerate—not invent—the commercial model.
Typical uses of capital
- scaling sales and marketing;
- expanding the product and engineering organization;
- building finance, legal, people and operating infrastructure;
- entering adjacent markets or geographies; and
- creating the governance and reporting expected by institutional investors.
What changes in the transaction
Negotiations usually extend well beyond valuation. Preferred-share rights may include liquidation preferences, anti-dilution protection, board representation, information rights, protective provisions, pro-rata rights and restrictions on future transactions.
Carta’s Q2 2026 U.S. benchmarks reported median rounds of US$4.5 million at seed, US$14.7 million at Series A and US$23.3 million at Series B. These figures are useful market context—not Canadian targets—and demonstrate why geography and stage definition must be considered when comparing rounds. See Carta’s Series A overview and benchmark data.
Series B, Series C and Later Rounds
Series B: accelerating proven growth
By Series B, the core question is usually whether the company can scale efficiently. Capital may support new markets, expanded distribution, senior leadership, acquisitions, production capacity or technology infrastructure.
Investors will typically examine cohort behaviour, gross margin, customer concentration, burn multiple, sales efficiency, forecast credibility, governance and the path to durable economics. The company is expected to have deeper management and more reliable reporting than at seed.
Series C and later: scale, strategic flexibility and liquidity
Later rounds may finance international expansion, acquisitions, major capital programs, new product lines or preparation for a public offering or strategic sale. Investors can include late-stage venture funds, growth-equity firms, private-equity investors, institutional investors and strategic corporations.
Some later-stage transactions include secondary shares, where existing shareholders sell shares and receive the proceeds. This differs from a primary financing, where the company issues shares and receives the capital. A financing can contain both components.
Growth equity
Growth equity is not limited to venture-backed technology companies. Established, revenue-generating businesses may raise minority or structured equity to fund acquisitions, geographic expansion, capacity or shareholder liquidity. The analysis may rely more heavily on financial performance, cash generation and a defined growth plan than on conventional venture-stage labels.
Other Terms Founders and Investors Encounter
Priced round
A priced round establishes a negotiated valuation and price per share at closing, usually through preferred shares. The documents set the investor’s economic and governance rights.
Convertible note or SAFE
A convertible instrument postpones the final equity price until a future financing or other triggering event. Discounts, valuation caps, interest, maturity, conversion mechanics and priority can materially affect dilution. A simple instrument is not necessarily a simple economic outcome.
Bridge round
Bridge capital is intended to carry the company to a defined event, such as a larger financing, profitability, regulatory approval or transaction. A bridge without a credible milestone and sufficient runway may only postpone a financing problem.
Extension round
An extension adds capital to an existing round, often on similar terms. It can accommodate another investor or provide additional runway without reopening the entire financing.
Up round, flat round and down round
These terms compare the new financing valuation with the prior round. A down round may increase dilution and activate anti-dilution provisions, but a realistic financing that protects the company can be preferable to defending an unsustainable valuation.
Strategic round
A customer, supplier or industry participant may invest for both financial and commercial reasons. Strategic capital can provide validation and access, but exclusivity, information rights or commercial restrictions may reduce future flexibility.
Warrants
A warrant gives the holder the right to purchase shares later at a defined price and during a defined period. Warrants may accompany debt or equity financing and should be included when modelling fully diluted ownership. Our guide to warrants in Canadian business financings explains their mechanics and implications.
How Much Should a Company Raise?
The amount should be built from the operating plan rather than selected because it resembles another company’s round.
- Define the next value-creating milestone. Examples include commercial launch, regulatory approval, a revenue target, a repeatable acquisition channel, a completed facility or cash-flow breakeven.
- Build the operating and cash-flow plan. Include hiring, product, selling costs, working capital, capital expenditures, transaction costs and contingencies.
- Allow sufficient runway. The company should not assume the next round closes exactly when cash is exhausted. Financing takes time and adverse markets can extend the process.
- Model dilution and the capitalization table. Include options, warrants, convertible instruments and the new investor—not merely the issued common shares.
- Test alternatives. Revenue, grants, customer financing, senior debt, venture debt or equipment financing may reduce dilution when the company can support them. Debt is not automatically cheaper if the business cannot comfortably service it.
The largest possible round is not always the best round. Excessive capital can create unnecessary dilution and an unrealistic valuation that makes the next financing more difficult. Too little capital can leave the company negotiating under pressure before it reaches the promised milestone.
Preparing for an Equity Financing
Investors are evaluating both the opportunity and the company’s ability to execute. A prepared issuer should be able to present:
- a clear investment thesis and use of proceeds;
- historical financial information and an integrated forecast;
- operating metrics appropriate to the business model;
- a current capitalization table showing options, warrants and convertibles;
- corporate records, material contracts and intellectual-property ownership;
- the management team, hiring plan and governance structure;
- principal risks and the plan to manage them; and
- a realistic financing timeline and investor strategy.
Canadian private-company financings must also comply with securities law. The issuer and its counsel need to identify an available prospectus exemption, determine investor eligibility, prepare appropriate subscription documents and complete required filings. The accredited-investor exemption is common, but it is not the only possible route and it should never be assumed. Our overview of accredited investors in Canada provides additional context.
The sequence of rounds is ultimately a record of how a company has converted capital into lower risk, stronger evidence and greater enterprise value. The right financing is the one that provides enough capital to reach the next important milestone while preserving a viable ownership, governance and capital structure.
Planning an equity raise, growth financing or strategic capital transaction? Review CFM’s capital-raising advisory approach or start a confidential conversation about the objective, required capital and financing strategy.
Sebastien Charles is the Founder and Managing Director of CFM Financial Consulting Inc. His experience spans entrepreneurship, corporate finance, M&A, capital raising, commercial financing, executive leadership and governance.
This article is provided for general informational purposes only and does not constitute legal, tax, accounting, investment, valuation or securities advice, or an offer or solicitation to buy or sell securities. Financing terms, investor eligibility and regulatory requirements depend on the specific circumstances. Issuers and investors should obtain advice from qualified professionals.
Related Capabilities
Related Insights
Capital Raising
Raising Capital for a Business in Canada
How debt, equity and strategic capital differ in cost, structure and ownership implications.
Capital Raising
What Are Warrants?
How warrants work and what issuers and investors should consider.
Private Capital
Accredited Investors in Canada
Who may qualify and the risks associated with private investments.